Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Hold
3,250
0.49% 57
2026
Q1
$1.14M Hold
3,250
0.53% 58
2025
Q4
$1.06M Hold
3,250
0.5% 58
2025
Q3
$917K Hold
3,250
0.45% 61
2025
Q2
$907K Hold
3,250
0.47% 65
2025
Q1
$1.01M Hold
3,250
0.55% 59
2024
Q4
$847K Buy
3,250
+125
+4% +$37.1K 0.43% 68
2024
Q3
$1.01M Hold
3,125
0.51% 62
2024
Q2
$976K Hold
3,125
0.53% 59
2024
Q1
$889K Hold
3,125
0.49% 64
2023
Q4
$900K Sell
3,125
-100
-3% -$27.2K 0.54% 57
2023
Q3
$867K Buy
3,225
+365
+13% +$91.1K 0.56% 60
2023
Q2
$635K Buy
2,860
+60
+2% +$13.9K 0.41% 67
2023
Q1
$677K Sell
2,800
-30
-1% -$7.36K 0.43% 70
2022
Q4
$743K Buy
2,830
+100
+4% +$26.8K 0.5% 64
2022
Q3
$615K Hold
2,730
0.46% 65
2022
Q2
$664K Buy
2,730
+205
+8% +$50.2K 0.47% 67
2022
Q1
$611K Hold
2,525
0.39% 75
2021
Q4
$568K Hold
2,525
0.35% 78
2021
Q3
$537K Hold
2,525
0.37% 76
2021
Q2
$615K Hold
2,525
0.4% 71
2021
Q1
$628K Hold
2,525
0.43% 67
2020
Q4
$581K Hold
2,525
0.43% 63
2020
Q3
$642K Hold
2,525
0.52% 57
2020
Q2
$596K Hold
2,525
0.52% 56
2020
Q1
$512K Hold
2,525
0.53% 57
2019
Q4
$609K Hold
2,525
0.49% 56
2019
Q3
$489K Hold
2,525
0.41% 67
2019
Q2
$465K Buy
+2,525
New +$452K 0.39% 69

Other funds holding AMGN

Westhampton Capital's AMGN Position: Q2 2026 in Review

Westhampton Capital held its Amgen (AMGN) position steady in Q2 2026 at 3,250 shares worth $1.18M. The position accounts for 0.49% of the portfolio, ranked #57.

Westhampton Capital first reported a position in AMGN in Q2 2019 and has held it in 29 quarters since. 1,152 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Westhampton Capital held 3,250 shares of Amgen worth $1.18M as of Q2 2026.
  • Westhampton Capital left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.49% of Westhampton Capital's portfolio in Q2 2026, its #57 holding.
  • Westhampton Capital first reported a position in Amgen in Q2 2019 and has held it in 29 quarters since.
  • 1,152 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Westhampton Capital's 13F filing for Q2 2026, filed 14 Jul 2026.